Literature DB >> 32266427

Exploring Evolutionary Constraints in the Proteomes of Zika, Dengue, and Other Flaviviruses to Find Fitness-Critical Sites.

Janelle Nunez-Castilla1, Jordon Rahaman1, Joseph B Ahrens1,2, Christian A Balbin1, Jessica Siltberg-Liberles3.   

Abstract

Dengue virus (DENV) challenges vaccine design due to antibody-dependent enhancement (ADE) and evidence suggests that Zika virus (ZIKV) experiences ADE with DENV and West Nile virus (WNV) antibodies. Thus, multiple flaviviruses must be considered when developing novel therapies against ZIKV. We analyzed 42 flavivirus polyproteins in their evolutionary context to identify motifs conserved in sequence with low real-time and evolutionary conformational flexibility, thought to be fitness-critical sites. We also analyzed evolutionary rate-shifts between clades for insight on vector specificity. For mosquito-borne flaviviruses, two conserved motifs were identified within the RNA-dependent RNA polymerase (RdRP), critical for flavivirus genome replication. Clade-specific motifs were identified for the ZIKV+DENV and WNV clades, many of which were also in RdRP. Six sites in motifs for WNV experienced significant evolutionary rate-shifts, suggesting their importance for functional divergence. Overall, some of these motifs are prime candidates as broadly neutralizing antiviral drug targets across different mosquito-borne flaviviruses.

Entities:  

Keywords:  Dengue virus; Evolutionary rates; Structural disorder; Vector specificity; West Nile virus; Zika virus

Year:  2020        PMID: 32266427     DOI: 10.1007/s00239-020-09941-5

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  98 in total

1.  Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues.

Authors:  Tal Pupko; Rachel E Bell; Itay Mayrose; Fabian Glaser; Nir Ben-Tal
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

2.  Rational drug design via intrinsically disordered protein.

Authors:  Yugong Cheng; Tanguy LeGall; Christopher J Oldfield; James P Mueller; Ya-Yue J Van; Pedro Romero; Marc S Cortese; Vladimir N Uversky; A Keith Dunker
Journal:  Trends Biotechnol       Date:  2006-07-28       Impact factor: 19.536

Review 3.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

4.  Structure fluctuations and conformational changes in protein binding.

Authors:  Anatoly M Ruvinsky; Tatsiana Kirys; Alexander V Tuzikov; Ilya A Vakser
Journal:  J Bioinform Comput Biol       Date:  2012-04       Impact factor: 1.122

Review 5.  Flaviviruses and flavivirus vaccines.

Authors:  Franz X Heinz; Karin Stiasny
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

6.  Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

Authors:  Hanna Retallack; Elizabeth Di Lullo; Carolina Arias; Kristeene A Knopp; Matthew T Laurie; Carmen Sandoval-Espinosa; Walter R Mancia Leon; Robert Krencik; Erik M Ullian; Julien Spatazza; Alex A Pollen; Caleigh Mandel-Brehm; Tomasz J Nowakowski; Arnold R Kriegstein; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-29       Impact factor: 11.205

7.  UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches.

Authors:  Baris E Suzek; Yuqi Wang; Hongzhan Huang; Peter B McGarvey; Cathy H Wu
Journal:  Bioinformatics       Date:  2014-11-13       Impact factor: 6.937

8.  Sofosbuvir: A novel treatment option for chronic hepatitis C infection.

Authors:  Harmeet Kaur Bhatia; Harmanjit Singh; Nipunjot Grewal; Navreet Kaur Natt
Journal:  J Pharmacol Pharmacother       Date:  2014-10

9.  Induction of endoplasmic reticulum-derived replication-competent membrane structures by West Nile virus non-structural protein 4B.

Authors:  Pakieli H Kaufusi; James F Kelley; Richard Yanagihara; Vivek R Nerurkar
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

10.  Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.

Authors:  Wanwisa Dejnirattisai; Piyada Supasa; Wiyada Wongwiwat; Alexander Rouvinski; Giovanna Barba-Spaeth; Thaneeya Duangchinda; Anavaj Sakuntabhai; Van-Mai Cao-Lormeau; Prida Malasit; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2016-06-23       Impact factor: 25.606

View more
  1 in total

1.  New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing Potential.

Authors:  Renato Kaylan Alves de Oliveira França; Jacyelle Medeiros Silva; Lucas Silva Rodrigues; Dimitri Sokolowskei; Marcelo Macedo Brigido; Andrea Queiroz Maranhão
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.